{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T21:10:10Z","timestamp":1781989810719,"version":"3.54.5"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2019.00031","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T08:40:45Z","timestamp":1550565645000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["The Combination Vaccine Adjuvant System Alum\/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization"],"prefix":"10.3389","volume":"9","author":[{"given":"Thomas","family":"Ebensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Delandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair","family":"Prochnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1073\/pnas.1424924112","article-title":"Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus","volume":"112","author":"Bagnoli","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.biopha.2018.06.026","article-title":"Efficacy and safety of immunological adjuvants. Where is the cut-off?","volume":"105","author":"Batista-Duharte","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B3","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.163.12.6448","article-title":"Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling","volume":"163","author":"Brewer","year":"1999","journal-title":"J. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nature10429","article-title":"STING is a direct innate immune sensor of cyclic di-GMP","volume":"478","author":"Burdette","year":"2011","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2010.09.013","article-title":"Vaccination strategies to promote mucosal antibody responses","volume":"33","author":"Chen","year":"2010","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin. Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1016\/j.vaccine.2016.10.039","article-title":"Vaccine safety evaluation: practical aspects in assessing benefits and risks","volume":"34","author":"Di Pasquale","year":"2016","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine Adjuvants: from 1920 to 2015 and Beyond","volume":"3","author":"Di Pasquale","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/2051013613501988","article-title":"Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants","volume":"1","author":"Dubensky","year":"2013","journal-title":"Ther. Adv. Vaccines"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3389\/fimmu.2017.01223","article-title":"Mucosal administration of cycle-Di-nucleotide-adjuvanted virosomes efficiently induces protection against influenza H5N1 in mice","volume":"8","author":"Ebensen","year":"2017","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4419-1132-2_13","article-title":"Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design","volume":"4","author":"Ebensen","year":"2008","journal-title":"Hum. Vaccin."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1016\/j.vaccine.2011.05.026","article-title":"Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1\/Th2\/Th17 promoting mucosal adjuvant","volume":"29","author":"Ebensen","year":"2011","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.vaccine.2006.10.033","article-title":"The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties","volume":"25","author":"Ebensen","year":"","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1128\/cvi.00119-07","article-title":"The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant","volume":"14","author":"Ebensen","year":"","journal-title":"Clin. Vaccine Immunol."},{"key":"B16","unstructured":"Common Ingredients in U.S. Licensed Vaccines [Online]. U.S. Food and Drug Administration2011"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","article-title":"From discovery to licensure, the Adjuvant System story","volume":"13","author":"Garcon","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2165\/11591760-000000000-00000","article-title":"Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach","volume":"25","author":"Gar\u00e7on","year":"2011","journal-title":"BioDrugs"},{"key":"B19","year":"2016","journal-title":"Global Health Estimates 2016: DALYs by Cause Globally"},{"key":"B20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.it.2016.07.001","article-title":"Triggering intracellular receptors for vaccine adjuvantation","volume":"37","author":"Gutjahr","year":"2016","journal-title":"Trends Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","article-title":"Advances in aluminum hydroxide-based adjuvant research and its mechanism","volume":"11","author":"He","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/mi.2010.8","article-title":"IL-10 production by CD4+ effector T cells: a mechanism for self-regulation","volume":"3","author":"Jankovic","year":"2010","journal-title":"Mucosal Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1003905","DOI":"10.1371\/journal.ppat.1003905","article-title":"Tailored immune responses: novel effector helper T cell subsets in protective immunity","volume":"10","author":"Kara","year":"2014","journal-title":"PLoS Pathog."},{"key":"B24","doi-asserted-by":"publisher","first-page":"F5","DOI":"10.1084\/jem.20011910","article-title":"Origin and homing of intestinal IgA antibody-secreting cells","volume":"195","author":"Lamm","year":"2002","journal-title":"J. Exp. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","article-title":"Recent advances of vaccine adjuvants for infectious diseases","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.vaccine.2009.12.045","article-title":"The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant","volume":"28","author":"Libanova","year":"2010","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ebiom.2017.07.016","article-title":"Type I IFN and not TNF, is essential for cyclic Di-nucleotide-elicited CTL by a cytosolic cross-presentation pathway","volume":"22","author":"Lirussi","year":"2017","journal-title":"EBioMedicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0005300","DOI":"10.1371\/journal.pntd.0005300","article-title":"Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi","volume":"11","author":"Matos","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coi.2017.06.005","article-title":"Old and new adjuvants","volume":"47","author":"McKee","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1084\/jem.20082874","article-title":"A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP","volume":"206","author":"McWhirter","year":"2009","journal-title":"J. Exp. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jconrel.2015.03.017","article-title":"Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination","volume":"206","author":"Mittal","year":"2015","journal-title":"J Control Release"},{"key":"B32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fimmu.2013.00129","article-title":"Regulation of adaptive immunity; the role of interleukin-10","volume":"4","author":"Ng","year":"2013","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/eji.201747150","article-title":"The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses","volume":"48","author":"Oleszycka","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.05.021.","article-title":"Novel vaccines: technology and development","author":"Patil","year":"2018","journal-title":"J. Allergy Clin. Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.2174\/15680266113136660183","article-title":"Vaccine adjuvants: key tools for innovative vaccine design","volume":"13","author":"Riese","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1003264","DOI":"10.1371\/journal.ppat.1003264","article-title":"Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine","volume":"9","author":"Ross","year":"2013","journal-title":"PLoS Pathog."},{"key":"B38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41541-017-0010-z","article-title":"Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection","volume":"2","author":"Sanchez Alberti","year":"2017","journal-title":"N.P. J. Vaccines"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.nano.2017.05.012","article-title":"Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice","volume":"13","author":"Schulze","year":"","journal-title":"Nanomedicine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1016\/j.nano.2017.08.015","article-title":"Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection","volume":"13","author":"Schulze","year":"","journal-title":"Nanomedicine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nsmb.2331","article-title":"Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system","volume":"19","author":"Shu","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3390\/pharmaceutics8010007","article-title":"Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators","volume":"8","author":"Tandrup Schmidt","year":"2016","journal-title":"Pharmaceutics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.coph.2018.05.003","article-title":"Combination and inducible adjuvants targeting nucleic acid sensors","volume":"41","author":"Temizoz","year":"2018","journal-title":"Curr. Opin. Pharmacol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00031\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:23:56Z","timestamp":1694633036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00031\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":43,"alternative-id":["10.3389\/fcimb.2019.00031"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2019.00031","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"article-number":"31"}}